Humacyte (HUMA) and JDRF Collaborate to Develop Insulin-Producing Biovascular Pancreas to Treat Type 1 Diabetes streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
NEW YORK, N.Y. and DURHAM, N.C., April 27, 2023 Humacyte, Inc. , a biotechnology company pioneering the development and manufacturing of off-the-shelf, universally implantable bioengineered. | April 27, 2023
TUESDAY, Nov. 8, 2022 (HealthDay News) Scientists have used a transplant procedure to apparently cure diabetes in lab mice, without the need for immune-suppressing drugs afterward.